InvestSMART

Archer Materials Limited (ASX: AXE) - Announcements

Current share price for AXE : $0.260 0.015 (5.45%)+

ASX company news and announcements for Archer Materials Limited (AXE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Archer Materials Limited (AXE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Archer Materials Limited (AXE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Archer Materials Limited (AXE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$66 Final Director's Interest Notice - KW 1 Dec 2025 2:32PM $0.360 $0.260 fallen by 27.78%
$66 Initial Director's Interest Notice - AJ 1 Dec 2025 2:32PM $0.360 $0.260 fallen by 27.78%
$66 Archer Board Changes 1 Dec 2025 2:31PM $0.360 $0.260 fallen by 27.78%
$66 Change of Director's Interest Notice - GE 20 Nov 2025 6:28PM $0.385 $0.260 fallen by 32.47%
$66 Notification regarding unquoted securities - AXE 20 Nov 2025 6:26PM $0.385 $0.260 fallen by 32.47%
$66 Results of 2025 Annual General Meeting 20 Nov 2025 12:13PM $0.380 $0.260 fallen by 31.58%
$66 AGM Presentation 20 Nov 2025 10:14AM $0.370 $0.260 fallen by 29.73%
$66 Chair's 2025 AGM address 20 Nov 2025 10:12AM $0.370 $0.260 fallen by 29.73%
$66 AXE achieves readout milestone towards qubit demonstration 20 Nov 2025 8:30AM $0.320 $0.260 fallen by 18.75%
$66 AXE & CSIRO - Quantum Machine Learning for fraud detection 10 Nov 2025 9:11AM $0.380 $0.260 fallen by 31.58%
$66 Notification of cessation of securities - AXE 3 Nov 2025 9:48AM $0.465 $0.260 fallen by 44.09%
$66 Silicon Biochip meets performance and clinical requirements 29 Oct 2025 9:17AM $0.385 $0.260 fallen by 32.47%
$66 Quarterly Activities/Appendix 4C Cash Flow Report 27 Oct 2025 8:23AM $0.410 $0.260 fallen by 36.59%
$66 Presentation - Semiconductor Australia 2025 22 Oct 2025 8:27AM $0.370 $0.260 fallen by 29.73%
$66 Notice of Annual General Meeting/Proxy Form 21 Oct 2025 4:19PM $0.370 $0.260 fallen by 29.73%
$66 Archer and Emergence partner to pursue graphene quantum tech 17 Oct 2025 9:26AM $0.380 $0.260 fallen by 31.58%
$66 AXE builds on EDMR breakthrough to advance qubit development 15 Oct 2025 12:45PM $0.300 $0.260 fallen by 13.33%
$66 Notice Required Under ASX Listing Rule 3.13.1 19 Sep 2025 8:25AM $0.295 $0.260 fallen by 11.86%
$66 Investor Presentation - September 2025 11 Sep 2025 8:27AM $0.263 $0.260 fallen by 0.95%
$66 Notification regarding unquoted securities - AXE 8 Sep 2025 4:40PM $0.275 $0.260 fallen by 5.45%
$66 Archer Strengthens Biochip Commercialisation Path 1 Sep 2025 8:29AM $0.275 $0.260 fallen by 5.45%
$66 2025 Corporate Governance Statement and Appendix 4G 28 Aug 2025 2:20PM $0.275 $0.260 fallen by 5.45%
$66 2025 Annual Report 28 Aug 2025 2:20PM $0.275 $0.260 fallen by 5.45%
$66 FY25 Results and Appendix 4E 28 Aug 2025 2:16PM $0.275 $0.260 fallen by 5.45%
$66 AXE to Unlock Scalable Potassium Sensor Production with IMEC 12 Aug 2025 8:39AM $0.265 $0.260 fallen by 1.89%

26 - 50 of 911 results

Page 2 of 37

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.